Vimta Labs
NSE: VIMTALABS · ISIN INE579C01029 · Healthcare
₹507.00+0.25 (+0.05%)
Monday 9 November, 13:31 IST. Delayed. Source: Yahoo Finance.
Price chart
₹507.00 +0.25 (+0.05%) today
The day
- Previous close
- ₹506.75
- Open
- ₹507.45
- Day high
- ₹510.80
- Day low
- ₹502.25
Listed on NSE since 15 December 2005.
Key numbers
- Market value
- ₹2,219.12 Cr
- P/E (trailing)
- 27.91
- EPS (trailing)
- ₹17.79
- Price to book
- 4.52
- Dividend yield
- 0.40%
- Return on equity
- 17.7%
- Debt to equity
- 0.03
- Profit margin
- 18.6%
- Beta
- 0.03
- Volume today
- 37,884
- Average volume
- 1.77 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹315.06 Cr | ₹48.17 Cr |
| FY24 | ₹288.60 Cr | ₹41.01 Cr |
| FY25 | ₹343.98 Cr | ₹67.34 Cr |
| FY26 | ₹407.29 Cr | ₹77.51 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹112 Cr | ₹21 Cr | +3.5% |
| Q1 FY27Apr–Jun 2026 | ₹109 Cr | ₹21 Cr | +11.4% |
| Q4 FY26Jan–Mar 2026Audited | ₹109 Cr | ₹21 Cr | +15.3% |
| Q3 FY26Oct–Dec 2025 | ₹99 Cr | ₹18 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹102 Cr | ₹20 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹98 Cr | ₹19 Cr | – |
Source: Vimta Labs’s results filed with NSE, standalone (the company alone). Net profit is the share of Vimta Labs’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹318 Cr | ₹318 Cr |
| Investments | ₹15 Cr | ₹2 Cr |
| Inventories | ₹29 Cr | ₹30 Cr |
| Owed by customers | ₹119 Cr | ₹106 Cr |
| Cash and equivalents | ₹37 Cr | ₹23 Cr |
| Total assets | ₹593 Cr | ₹562 Cr |
| Borrowings | ₹14 Cr | ₹3 Cr |
| Total liabilities | ₹102 Cr | ₹105 Cr |
| Shareholders’ equity | ₹491 Cr | ₹457 Cr |
Source: Vimta Labs’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.
About Vimta Labs
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.
- Industry
- Diagnostics & Research
- Based in
- Hyderabad
- Employees
- 1,384
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Vimta Labs in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 2 Per Share
Dividend · ex-date 18 June 2026
- Bonus 1:1
Bonu · ex-date 13 June 2025
- Dividend - Rs 2 Per Share
Dividend · ex-date 30 May 2025
- Annual General Meeting/Dividend - Rs 2 Per Share
Dividend · ex-date 11 July 2024
- Annual General Meeting/Dividend - Rs 2 Per Share
Dividend · ex-date 21 June 2023
- Annual General Meeting/Dividend - Rs 2 Per Share
Dividend · ex-date 16 June 2022
- Annual General Meeting/Dividend - Rs 2 Per Share
Dividend · ex-date 25 June 2021
- Annual General Meeting
Action · ex-date 1 September 2020
Source: NSE. Latest first, 8 of 20.
Information only, not investment advice. Prices are delayed.